Kyle Woodley

Kyle Woodley

Kyle Woodley is the Senior Investing Editor of Kiplinger.com. His articles covering stock picks, exchange-traded funds and mutual funds have been featured on MSN, Nasdaq and U.S. News & World Report. He also has appeared on Fox Business Network.

He previously was Managing Editor of InvestorPlace.com, and an award-winning designer and copy editor with Gannett. He also is a graduate of Ohio State University.

Kyle can be reached at kwoodley@kiplinger.com, or you can follow him on Twitter at @KyleWoodley.

Recent Articles

5 Ways to Make New Year’s Resolutions REALLY Pay Off

From dieting to quitting smoking to traveling, those promises everyone makes every year create lots of spending. And you can cash in on it, too.

Biotech Movers: Sequenom Soars on Blood Test Success

SONM sees significant gains despite a sub-par earnings report. Plus: Why Array and Vivus took big falls.

Biotech Movers: Enzo Biochem Rockets on Patent Ruling

ENZ is awarded $48.6 million in penalties, and more could be coming. Plus: Why Abiomed, Pain Therapeutics, Impax and BioCryst all took big falls.

The 7 Worst Dow Dividend Stocks for October

Sure, some of these Dow Jones companies have a few things going for them, but their skimpy dividends don't win them any friends among income investors.

PowerShares’ High-Dividend ETF: Good Fund, GREAT Sales Pitch

PowerShares' new high-dividend, low-volatility fund SPHD has several attractive selling points and is well-timed to capture the current thirst for yield.